AstraZeneca set to licence 5 programmes from Transgène SA

Transgène SA and AstraZeneca plc have entered into a collaboration and exclusive license option agreement on Transgène’s armed oncolytic immunotherapies.

Read more

Alentis Therapeutics debuts with CHF12.5m

Liver specialist Alentis Therapeutics AG has raised CHF12.5m in a Series A round co-led by BioMedPartners and BB Pureos Bioventures.

Read more

EMA recommends nine drugs for market approval

In its first meeting in Amsterdam, the CHMP of the European Medicines Agency recommended six new drugs, two orphan meds, and one biosimilar for EU market authorisation.

Read more

A novel strategy against rheumatoid arthritis

Researchers at AstraZeneca, Viela Bio, Gilead Sciences, Antidote Therapeutics Inc., and at SoseiHeptares report on a new small molecule compound  to treat RA.

Read more

US patent office grants Charpentier CRISPR patent

The US Patent Office has granted the Charpentier/Doudna key CRISPR patent, which was previously involved in an interference proceeding.
 

Read more

European Parliament greenlights Horizon Europe priorities

As a first result of the trilogue on the €100m+ Horizon Europe programme, MEPs backed the backbone of the EU’s future research and innovation programme.

Read more

Biotechpharma UAB expanding production

Lituanian CDMO Biotechpharma UAB has invested €50m in order to expand its production capacity to 5000 litres.

Read more

Kiadis Pharma NV to acquire CytoSen Therapeutics, Inc.

Kiadis Pharma NV has entered a definitive agreement to acquire US-based CytoSen Therapeutics, Inc. in order to create a leader in cell-based cancer immunotherapy.

Read more

Treating diabetes by mimicking gut bacteria effects

Researchers at University of Glasgow report that modulation of a specific GPCR results in health benefits normally mediated by a healthy gut microbiome.

Read more

Immunic lists at Nasdaq

Chronic inflammatory disease company Immunic Therapeutics starts Nasdaq-trade following merger with Vital Therapies.
 

Read more